V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290003988 | 290002958 | 0 | null | Curative (C) | 2013-04-26 | 2013-05-24 | Carboplatin + Pemetrexed | N | Y | 290020371 | MITOMYCIN INTRAVESICULAR |
| 290003989 | 290002959 | 1.7 | 88 | Adjuvant (A) | 2014-02-17 | 2014-03-10 | CISPLATIN + VINORELBINE | 02 | N | 290020372 | NOT MATCHED |
| 290003990 | 290002959 | null | null | Neo-adjuvant (N) | 2016-11-09 | 2016-11-26 | GemCarbo Days 1+8 | 02 | N | 290020372 | LANREOTIDE |
| 290003991 | 290002960 | 1.56 | null | null | null | 2018-01-17 | CETUXIMAB + RT | null | null | 290020376 | CETUXIMAB + RT |
| 290003992 | 290002961 | 1.94 | 0 | Palliative (P) | 2017-09-27 | 2017-11-01 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 290020377 | CARBOPLATIN + PACLITAXEL |
| 290003993 | 290002962 | null | 75.5 | Palliative (P) | 2018-11-12 | 2018-12-03 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 290020378 | INTERAACT TRIAL |
| 290003994 | 290002963 | 1.66 | 118 | Palliative (P) | 2016-10-19 | 2016-10-29 | Capecitabine + Cisplatin | 02 | N | 290020379 | EOX |
| 290003995 | 290006397 | 1.52 | 50.3 | Palliative (P) | 2017-08-12 | 2017-08-19 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | N | 290020380 | CAPECITABINE + RT |
| 290003996 | 290006397 | 1.61 | null | Curative (C) | 2016-06-12 | 2016-06-12 | LANREOTIDE | Y | N | 290020380 | LANREOTIDE |
| 290003997 | 290008171 | 1.68 | 92 | Curative (C) | 2015-05-20 | 2015-06-10 | CISPLATIN + FLUOROURACIL | 02 | N | 290020383 | ECX |
| 290003998 | 290008171 | 1.66 | null | Curative (C) | 2013-06-22 | 2013-06-30 | ECX | 02 | N | 290020383 | GEMCARBO |
| 290003999 | 290008171 | 1.7 | 83.1 | Palliative (P) | 2013-04-10 | 2013-04-24 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 290020383 | FLUOROURACIL |
| 290004000 | 290002964 | 1.89 | 97 | Adjuvant (A) | 2013-05-08 | 2013-05-15 | LANREOTIDE | N | N | 290020388 | CAPECITABINE + RT |
| 290004001 | 290002965 | null | null | Curative (C) | 2013-10-23 | 2013-11-04 | OCTREOTIDE | null | N | 290020389 | LANREOTIDE |
| 290004002 | 290002966 | 1.78 | 68 | Adjuvant (A) | 2014-07-09 | 2014-07-10 | ECX | 02 | N | 290020391 | CAPECITABINE |
| 290004003 | 290002967 | 1.75 | null | Palliative (P) | 2014-06-04 | 2014-07-01 | Carbo F | Y | null | 290020392 | CISPLATIN + GEMCITABINE |
| 290004004 | 290006398 | 1.78 | 66.8 | Palliative (P) | 2016-11-13 | 2016-12-10 | Trial Unspecified | N | N | 290020394 | CETUXIMAB + RT |
| 290004005 | 290006398 | null | 82.4 | Adjuvant (A) | 2013-03-27 | 2013-03-27 | Capecitabine | N | N | 290020394 | CISPLATIN + FLUOROURACIL |
| 290004006 | 290008172 | 1.51 | 68.6 | Palliative (P) | 2017-12-30 | 2018-01-26 | EOX | 2 | N | 290020396 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 290004007 | 290008172 | 1.7 | 61.8 | Curative (C) | 2018-06-21 | 2018-07-17 | EOX | N | Y | 290020396 | CAPECITABINE |
| 290004008 | 290008172 | 0 | 0 | Palliative (P) | 2017-03-04 | 2017-04-06 | Irinotecan + Modified De Gramont | N | N | 290020396 | CETUXIMAB |
| 290004009 | 290002968 | null | 93.7 | Curative (C) | 2015-02-14 | 2015-02-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 290020400 | PEMBROLIZUMAB |
| 290004010 | 290002969 | 1.76 | null | null | 2016-12-21 | 2017-01-17 | CHOP R - 21 days | N | N | 290020402 | CETUXIMAB |
| 290004011 | 290002969 | 1.69 | 84 | Neo-adjuvant (N) | 2017-07-18 | 2017-08-01 | CARBOPLATIN + RT | N | Y | 290020402 | CARBOPLATIN + ETOPOSIDE |
| 290004012 | 290002970 | null | null | Adjuvant (A) | 2017-09-03 | 2017-09-24 | Cisplatin + Vinorelbine (IV) | N | N | 290020407 | CVD |
| 290004013 | 290002971 | 1.7 | 83.5 | Palliative (P) | 2017-01-16 | 2017-01-22 | OCTREOTIDE | N | N | 290020408 | CISPLATIN + FLUOROURACIL |
| 290004014 | 290002972 | 1.68 | 63.2 | Neo-adjuvant (N) | 2019-06-01 | 2019-06-01 | KESTREL Trial | N | Y | 290020409 | CAPECITABINE + CISPLATIN |
| 290004015 | 290002972 | 1.8 | 88.5 | Palliative (P) | 2014-06-16 | 2015-02-12 | Capecitabine 42days + RT | 02 | N | 290020409 | LANREOTIDE |
| 290004016 | 290007700 | 1.81 | 97 | null | 2017-01-16 | 2017-01-19 | Chlorambucil | 02 | null | 290020413 | FLUOROURACIL |
| 290004017 | 290002973 | 1.8 | 50 | Palliative (P) | 2016-02-18 | 2016-04-12 | Fluorouracil + Folinic Acid Weekly | N | N | 290020415 | FLUOROURACIL |
| 290004018 | 290002974 | 1.57 | null | Curative (C) | 2017-02-08 | 2017-02-26 | Fluorouracil 96hr infusion+R(4g/m2) | Y | N | 290020418 | CISPLATIN + ETOPOSIDE |
| 290004019 | 290002975 | 1.69 | null | null | 2015-07-28 | 2015-07-29 | Capecitabine 35days + RT | 02 | null | 290020421 | LANREOTIDE |
| 290004020 | 290002976 | 1.86 | 68 | Disease modification (D) | null | 2016-03-18 | FLUOROURACIL | N | N | 290020422 | EOX |
| 290004021 | 290002976 | 1.72 | 94.7 | Palliative (P) | 2015-04-08 | 2015-04-08 | CARBOPLATIN | 2 | N | 290020422 | CAPECITABINE + CISPLATIN |
| 290004022 | 290002976 | 1.65 | null | Palliative (P) | 2016-10-17 | 2016-11-07 | GemCarbo Days 1+8 | N | N | 290020422 | MITOMYCIN |
| 290004023 | 290002977 | 1.7 | 70 | Adjuvant (A) | 2017-05-22 | 2017-05-26 | CARBOPLATIN + RT | 02 | N | 290020426 | CARBOPLATIN + RT |
| 290004024 | 290002978 | null | 57.3 | Palliative (P) | 2015-05-21 | 2015-06-03 | RUXOLITINIB | N | N | 290020427 | LANREOTIDE |
| 290004025 | 290002979 | 1.7 | 73 | Not known (9) | null | 2017-01-05 | Capecitabine | null | null | 290020430 | CAPECITABINE + CISPLATIN |
| 290004026 | 290006402 | 1.85 | 67.6 | null | 2014-11-21 | 2014-12-12 | Capecitabine 35days + RT | N | N | 290020431 | TRIAL |
| 290004027 | 290002980 | null | 61.61 | Palliative (P) | 2017-01-10 | 2017-01-10 | CETUXIMAB + RT | N | N | 290020432 | TRIAL |
| 290004028 | 290002981 | 1.61 | 61 | null | 2014-03-15 | 2014-03-17 | Sorafenib | 2 | null | 290020433 | EOX |
| 290004029 | 290002982 | null | 93.7 | Palliative (P) | null | 2016-07-12 | CETUXIMAB | N | N | 290020434 | CETUXIMAB + RT |
| 290004030 | 290002983 | 1.8 | 89 | Disease modification (D) | 2014-11-04 | 2014-11-08 | ECX | N | N | 290020436 | CARBOPLATIN + CETUXIMAB + FU |
| 290004031 | 290002984 | null | 72 | Curative (C) | 2014-02-01 | 2014-03-01 | Gemcitabine weekly | 02 | Y | 290020438 | CAPECITABINE |
| 290004032 | 290002985 | 1.66 | 87.1 | Disease modification (D) | 2015-10-03 | 2015-10-16 | Temozolomide + RT | 2 | N | 290020442 | LANREOTIDE |
| 290004033 | 290002986 | null | 55 | Adjuvant (A) | 2017-03-08 | 2017-03-08 | LANREOTIDE | N | N | 290020443 | CARBOPLATIN + RT |
| 290004034 | 290006403 | null | null | null | 2015-01-31 | 2015-02-05 | OCTREOTIDE | 02 | N | 290020445 | BENDAMUSTINE + RITUXIMAB |
| 290004035 | 290002987 | 1.83 | null | Curative (C) | 2013-01-28 | 2013-03-11 | ECX | 02 | Y | 290020447 | CETUXIMAB + RT |
| 290004036 | 290002988 | 1.68 | 55.9 | Neo-adjuvant (N) | 2015-01-21 | 2015-02-10 | Capecitabine 35days + RT | N | Y | 290020449 | EVEROLIMUS |
| 290004037 | 290002989 | 1.63 | 59 | Palliative (P) | 2015-08-11 | 2015-08-25 | OCTREOTIDE | N | N | 290020451 | BEVACIZUMAB + CAPE + OXALIPLATIN |